Mix Sector Stocks: Rexahn Pharmaceuticals (NYSEMKT:RNN), Freeport-McMoRan Inc. (NYSE:FCX), Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), Lantronix (NASDAQ:LTRX), ESCO Technologies Inc. (NYSE:ESE)

Zacks upgraded shares of Rexahn Pharmaceuticals (NYSE:RNN) from a neutral rating to an outperform rating in a report issued on Tuesday. They currently have $0.80 target price on the stock. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) in last trading activity moved down -0.57% to close at $0.70. Company weekly performance is -2.64% while its quarterly performance stands at -17.53%. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) is -62.11% away from its 52 week high.

On Dec 23, Freeport-McMoRan (NYSE:FCX) reported that the company needs to build two Indonesian copper smelters at a cost of around $4 billion by 2020, a government official told Reuters, as talks resumed between the miner and Jakarta over the firm’s future in the Southeast Asian country, Reuters reports. On last trading day Freeport-McMoRan Inc. (NYSE:FCX) increased 2.62% to close at $23.51. Its volatility for the week is 3.49% while volatility for the month is 3.71%. FCX’s sales growth for past 5 years was 3.30% and its EPS growth for past 5 years was 16.80%. Freeport-McMoRan Inc. (NYSE:FCX) monthly performance is -19.71%.

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announces that its partner Spectrum Pharmaceuticals (NASDAQ: SPPI) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Captisol-enabledâ„¢ Melphalan (CE-Melphalan) HCl for injection (propylene glycol-free) for use as a high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) in last trading activity advanced 2.26% to close at $52.96. Company weekly performance is 1.59% while its quarterly performance stands at 10.52%. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) is -34.15% away from its 52 week high.

On Dec 16, UK-based Torquing Group has tapped Lantronix, Inc. (NASDAQ: LTRX), to provide secure, onboard Wi-Fi technology for its new ZANO nano drone, an aerial photography and HD video capture nano platform that allows users to instantly begin capturing and sharing moments like never before. Lantronix, Inc. (NASDAQ:LTRX) has 1.00% insider ownership while its institutional ownership stands at 24.80%. In last trading activity company’s stock closed at $1.91.

ESCO Technologies (NYSE:ESE) Director Larry W. Solley unloaded 4,000 shares of ESCO Technologies stock in a transaction dated Monday, December 1st. The shares were sold at an average price of $35.77, for a total value of $143,080.00. On Friday shares of ESCO Technologies Inc. (NYSE:ESE) closed at $37.38. Company’s sales growth for last 5 years was -3.00% and EPS growth for next 5 years is recorded as 12.50%.

Leave a Reply

Your email address will not be published. Required fields are marked *